Efficacy News and Research

RSS

Purified omega-3 and aspirin reduce pre-cancerous bowel polyps, shows study

Both aspirin and a purified omega-3, called EPA, reduce the number of pre-cancerous polyps in patients found to be at high risk of developing bowel cancer, according to new research.

20 Nov 2018

FDA approves antibacterial drug to treat travelers' diarrhea

The U.S. Food and Drug Administration today approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with travelers' diarrhea caused by noninvasive strains of Escherichia coli (E. coli), not complicated by fever or blood in the stool.

17 Nov 2018

Researchers produce 3D chemical maps of small biological samples

Scientists at the National Synchrotron Light Source II --a U.S. Department of Energy (DOE) Office of Science User Facility at DOE's Brookhaven National Laboratory--have used ultrabright x-rays to image single bacteria with higher spatial resolution than ever before.

16 Nov 2018

EMA recommends first all-oral treatment to tackle deadly sleeping sickness

The European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive scientific opinion of fexinidazole, the first all-oral treatment that has been shown to be efficacious for both stages of sleeping sickness.

16 Nov 2018

American Cancer Society study links social isolation to higher mortality risk

A large American Cancer Society study links social isolation with a higher risk of death from all causes combined and heart disease for all races studied, and with increased cancer mortality in white men and women.

16 Nov 2018

Report reveals increase in pancreatic cancer death rates across Europe

Pancreatic cancer death rates in the European Union have increased by 5% between 1990 and 2016, a report launched today reveals. This is the highest increase in any of the EU’s top five cancer killers which, as well as pancreatic cancer, includes lung, colorectal, breast and prostate cancer.

15 Nov 2018

Mylan and Biocon launch new insulin glargine biosimilar in the UK

Mylan N.V. and Biocon Ltd. today announced the UK launch of Semglee (Insulin Glargine solution for injection in pre-filled pen) 100 units/mL, an approved biosimilar of reference insulin glargine.

From Viatris Inc. 15 Nov 2018

Researchers evaluate efficacy of salivary biomarkers for early detection of oral cancer

Over 90% of malign tumors in the head and neck are originated from carcinomas of squamous cells that appear in superficial areas of the oral cavity. Their detection with salivary biomarkers can contribute to their early treatment, before they transform into tumors.

14 Nov 2018

Individual and work-related factors may help promote hospital physician engagement, finds study

Individual and work-related factors may be helpful in promoting positive engagement with work among hospital physicians, according to a study in the December issue of Medical Care. The journal is published in the Lippincott portfolio by Wolters Kluwer.

14 Nov 2018

Precision medicine-based approach to slow or reverse biologic drivers of Alzheimer's disease

Alzheimer's disease is a progressive, neurodegenerative condition in which individuals exhibit memory loss, dementia, and impaired metabolism.

14 Nov 2018

Umass Amherst researchers battle against youth suicide in rural Alaska Native communities

As the nights grow longer and winter settles in across the north, a team of health researchers is using a "community mobilization" approach to translate research into practice for an Alaska Native youth suicide prevention program in 15 remote Alaska towns.

13 Nov 2018

Hands-Only CPR training kiosks can teach life-saving skills in just minutes

Prompt action from a bystander can impact the likelihood a person survives cardiac arrest that occurs outside of a hospital. One common and proven intervention that anyone can learn is Hands-Only Cardiopulmonary Resuscitation.

12 Nov 2018

Diabetes medication reduces risk of heart failure hospitalization

In the largest trial to date to assess cardiovascular outcomes for an important class of diabetes medications, researchers have found that dapagliflozin markedly reduced the risk of hospitalization for heart failure in a broad population of patients with diabetes.

12 Nov 2018

The Human Mini Heart-in-a-Jar That Could One Day Replace Animal Testing

An interview with Dr. Kevin Costa, discussing the miniaturized heart-in-a-jar model developed by Novoheart, and its applications in personalized medicine.

12 Nov 2018

Stem cells transplanted for treatment of Parkinson’s disease

Japanese researchers have last week transplanted stem cells into a patient’s brain as part of an experimental therapy for Parkinson’s disease. The team at Kyoto University used induced Pluripotent Stem (iPS) cells for their procedure. These iPS cells have the capacity to turn into any cell in the body.

11 Nov 2018

Potential treatment for rare polio-like illness shows no signal of efficacy

Researchers have been searching for possible treatments for the polio-like illness causing paralysis in children, called acute flaccid myelitis.

9 Nov 2018

New single-dose antibiotic effectively treats uncomplicated gonorrhea infections

A phase 2 clinical trial led by Stephanie N. Taylor, MD, Professor of Medicine and Microbiology in the Section of Infectious Diseases at LSU Health New Orleans School of Medicine, has found that a new antibiotic effectively treats uncomplicated urogenital and rectal gonorrhea infections in a single oral dose.

9 Nov 2018

New thrombolytic based on magnetite nanoparticles successfully tested on animals

New anti-thrombosis drug based on magnetite nanoparticles developed at ITMO University was successfully tested on animals. Preclinical studies conducted in terms of the project "PHARMA 2020" showed drug's high efficacy and no side effects.

9 Nov 2018

WHO revise treatment guidelines of lymphatic filariasis due to CWRU-led study

Researchers from Case Western Reserve University School of Medicine have shown that a single "cocktail" of three pill-based anti-parasite medications is significantly more effective at killing microscopic larval worms in people diagnosed with lymphatic filariasis, commonly known as elephantiasis, than other standard two-drug combinations previously used in the global effort to eliminate this infectious disease.

9 Nov 2018

Bfr organizes symposia for research on viruses and antimicrobial resistance in food chain

Against this background, the German Federal Institute for Risk Assessment is organising two symposia dealing with microbial risks in food in November 2018: "Food-associated viruses" on 7 November and "Antimicrobial resistance in the food chain" on 8/9 November.

9 Nov 2018